What is TAGMe
Worldwide exclusive: Tumor Aligned General Methylated Epiprobe (TAGMe)
In the verification of more than 3000 clinical samples, the methylation level of TAGMe in tumor tissues was significantly higher than that of normal tissues. Therefore, TAGMe can be applied as a pan-cancer marker to the detection of various cancers.
Histone-related genes are hypermethylated in lung cancer and hypermethylated HIST1H4F could serve as a pan-cancer biomarker
As a pan-cancer marker, TAGMe has high specificity and sensitivity in clinical sample verification, which has indispensable reference value for the clinical diagnosis of tumors.
TAGMe’s sensitive in different tumor samples when the specificity is greater than 95%,